PAM
ATYR

Panagora Asset Management’s aTyr Pharma ATYR Stock Holding History

Panagora Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-47
Closed – – 2649
2019
Q2 		$0 Sell
47
-148
-76% -$1K ﹤0.01% 2682
2019
Q1 		$1K Hold
195
– – ﹤0.01% 2481
2018
Q4 		$1K Sell
195
-1,162
-86% -$9.73K ﹤0.01% 2432
2018
Q3 		$15K Sell
1,357
-58
-4% -$635 ﹤0.01% 2262
2018
Q2 		$18K Buy
1,415
+1
+0.1% +$24 ﹤0.01% 2204
2018
Q1 		$52K Buy
1,414
+817
+137% +$38.3K ﹤0.01% 2019
2017
Q4 		$29K Buy
+597
New +$36.7K ﹤0.01% 2133
2015
Q4 		– Sell
-423
Closed -$61K – 2372
2015
Q3 		$61K Buy
+423
New +$96.4K ﹤0.01% 1945

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return

Panagora Asset Management's ATYR Position: Q3 2019 in Review

Panagora Asset Management sold out of aTyr Pharma (ATYR) in Q3 2019, closing a stake of 47 shares.

Panagora Asset Management first reported a position in ATYR in Q3 2015 and held it in 8 quarters. The position peaked at $61K in Q3 2015. 19 funds tracked by Wall St. Rank hold ATYR as of Q3 2019.

  • Panagora Asset Management reported no remaining aTyr Pharma position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 47 aTyr Pharma shares in Q3 2019.
  • Panagora Asset Management first reported a position in aTyr Pharma in Q3 2015 and held it in 8 quarters.
  • Panagora Asset Management's aTyr Pharma position peaked at $61K in Q3 2015.
  • 19 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.